IMF's Chief Economist Gita Gopinath will leave her job in January next year and return to the prestigious Harvard University, according to the global financial institution.
A total of 27,920 people have been cured of the disease with 1,685 in the last 24 hours, taking the recovery rate to 34.06 per cent, the ministry said.
The former McKinsey India head is presently on board of many big Indian conglomerates.
Nobel Laureate economist Amartya Sen on Tuesday expressed scepticism about Prime Minister Narendra Modi's idea of secularism, asserting he would like to see "more action" in reaching out to the minorities.
Pollution is biggest reason behind the spike in COVID-19 cases in Delhi. We had situation under control until October 20, the CM said.
COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India
'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'
The country also reported 3,397 fresh COVID-19 cases, including 169 from dormitories for migrant workers.
By 2030 India will be among top three countries in science and technology: PM
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
'Most students find it difficult to cope with the way they are expected to learn at the IITs.' 'So, all the students face the same stress.' 'But those students who are mentally weak are more affected.'
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.
Fundraising activity in the upcoming financial year 2022-23 may even surpass FY22 when 52 Indian companies raised a record Rs 1.11 trillion via initial public offerings (IPOs). According to a note by PRIME Database, 54 companies (including LIC) plan to raise Rs 1.4 trillion and currently hold the Securities and Exchange Board of India's (Sebi's) approval. Another 43 companies, the note said, are looking to raise about Rs 81,000 crore but waiting for Sebi nod.
The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
Do we really need to wait for a special day to be reminded of our country's rich heritage and culture, asks author and management guru Virender Kapoor.
With these states imposing lockdowns anew, the health ministry emphasised that the restrictions should be utilised to focus on containment, surveillance and testing in the containment and buffer zones as the key strategy for early detection of cases and fatality management.
The Forbes 30 Under 30 list is harder to get into than Stanford or Harvard University. Meet the desis who made the cut this year.
Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.
Hercules Singh Munda's father used to open the gates to a forest. Today, Hercules leaves for London to open the gates of his many dreams.
Thanks to technological support provided by BlinkIN, a Bengaluru-based intelligent visual-assistance company, engineers in Wuhan were able to remotely install air ventilation systems in two hospitals in Wuhan, the epicentre of the coronavirus pandemic, reports Peerzada Abrar.
Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.
'In the earlier waves, doubling of cases was happening at an interval of 4-6 days.' 'But in the case of omicron the doubling time we are seeing is in the range of 2-4 days.'
The recent protests by employees of Urban Company and the case of a a Zomato delivery executive who died in a road accident point to the severely straitened condition of gig workers during the ongoing Covid-19 pandemic. Budget 2021 had promised several measures to help the cause of gig economy workers, but most of them are yet to see the light of day. Even after a year, the country's gig workers continue to be without any social security cover or a minimum wage guarantee. "In Budget 2021, finance minister Nirmala Sitharaman had announced that the government is looking toward including migrant and gig workers for social security benefits," says Srinivas Kotni, managing partner, Lexport, a consulting firm. Parliament had passed the Code on Wages in 2019 and Code on Industrial Relations, Social Security and Occupational Safety, Health and Working Conditions in 2020.
Balasubramanian, 50, Herchel Smith Professor of Medicinal Chemistry at Cambridge University, has been recognised for his work as a co-inventor of Next Generation DNA sequencing, described as the most transformational advance in biology and medicine for decades.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
While a coordinated aggressive monetary easing from the central banks is most likely to offer some respite in the near-term, it is unlikely to improve the sentiments.
The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.
Whether the third wave will ravage us depends on the pace of vaccinations, careful and calibrated opening up of establishments, and a strategy to contain the spread in specific states or pockets.
In a letter to the Business School community on Wednesday, Nohria said he will step down from the position of dean of the Harvard Business School (HBS) on June 30, 2020, after a decade in the role.
Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.
The COVID-19 test of the MPs need to be done 72 hours before the start of the session and it can be done either in their constituencies or at the Parliament complex.
The awardees included one Padma Vibhushan, 11 Padma Bhushan and 44 Padma Shri.
These foods will help you fight hypertension and lower blood pressure, says Dr Udgeath Dhir.
India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.
'When people feel they are trusted, they invariably do their best, both as individuals and as a collective team.'
Concerned by GDP slowdown and unrealistic tax targets, the economists urged Finance Minister Nirmala Sitharaman to implement long-term structural steps like land and labour reforms. Warning against any off-Budget financing the economists said the government should prepare a statement of intent for its social, rural and welfare sector expenditure.
While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.
All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
'If things don't work on the ground and they continue moving at this pace, it will vanish.'
